Almost a third of people with advanced pancreatic cancer taking part in an ongoing clinical trial had stable disease…
Articles by Marisa Wexler, MS
Advocates across North America are launching a wave of fundraisers and educational campaigns this week as May kicks off Brain…
The U.S. Food and Drug Administration (FDA) has granted fast track status to a combination of lunresertib and zedoresertib —…
The Center for Cancer and Blood Disorders (CCBD), a network of community-based oncology practices across Maryland, has launched…
The European Commission has approved Ipsen’s oral therapy Ojemda (tovorafenib) to treat certain children with…
In an early clinical trial, people with certain advanced or treatment-resistant gynecological cancers showed strong responses to the experimental…
The U.S. Food and Drug Administration (FDA) has granted fast track status to Opna Bio‘s OPN-6602 as…
AML World Awareness Day, an annual effort to educate people about acute myeloid leukemia (AML), is coming up on…
Most people with previously-treated metastatic pancreatic cancer lived for at least one year after receiving the oral therapy candidate…
The U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation to plixorafenib as a potential treatment for adults…